Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Historical Acquisition Tree
Alternative names
grapiprant (2 trials)
pembrolizumab (keytruda) (2 trials)
Adenocarcinoma (Phase 2)
Adenocarcinoma of Lung (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Colorectal Neoplasms (Phase 1)
Lung Neoplasms (Phase 2)
Trials (2 total)
Trial APIs (2 total)